Search Tag: VITROS® SARS-CoV-2 Antigen Test

ICU Management

2021 13 Apr

Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it received CE Marking for its VITROS® SARS-CoV-2 Antigen Test, initially launched in October 2020. The CE Mark allows for more convenient sample collection and expanded viral transport media. Updates to Ortho’s COVID-19...Read more